Drug Profile
Research programme: MIF inhibitors - Debiopharm/Yale
Alternative Names: Macrophage Migration Inhibitory Factor inhibitorsLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Debiopharm Group
- Developer Debiopharm Group; Yale University
- Class Small molecules
- Mechanism of Action Macrophage migration inhibitory factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders; Inflammation
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Autoimmune-disorders in USA
- 28 Jul 2018 No recent reports of development identified for research development in Inflammation in USA
- 06 May 2014 Early research in Autoimmune disorders in USA (unspecified route)